IVZ
48
5
OXY
42
6
DHR
56
-4
GOOG
61
2
HST
52
3
TMO
58
-2
MTCH
44
4
O
37
-3
ROP
60
-5
DUK
64
-5
RCL
72
-2
PRU
54
4
ZTS
63
3
FOXA
41
4
WM
62
-6
KEY
53
3
NWS
41
4
NWSA
47
4
TSCO
57
-3
AAP
23
2
IVZ
48
5
OXY
42
6
DHR
56
-4
GOOG
61
2
HST
52
3
TMO
58
-2
MTCH
44
4
O
37
-3
ROP
60
-5
DUK
64
-5
RCL
72
-2
PRU
54
4
ZTS
63
3
FOXA
41
4
WM
62
-6
KEY
53
3
NWS
41
4
NWSA
47
4
TSCO
57
-3
AAP
23
2
Financhill
Back

Neurogene Stock Predictions

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Sell
40

NGNE
Neurogene

Last Price:
41.53
Seasonality Move:
-0.92%

7 Day Trial

ALL ACCESS PASS

$ 7

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Neurogene Stock Forecast

  • Over the next 52 weeks, Neurogene has on average historically risen by 31.2% based on the past 10 years of stock performance.
  • Neurogene has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Neurogene Stock Undervalued?
    The current Neurogene [NGNE] share price is $40.27. The Score for NGNE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Neurogene Stock Go Up Next Year?

  • Over the next 52 weeks, Neurogene has on average historically risen by 31.2% based on the past 10 years of stock performance.

Neurogene Stock Rating

Sell
40
Neurogene (NGNE) is a Sell

Is Neurogene overpriced?

  • Neurogene has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Neurogene Stock Price History

Is NGNE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NGNE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com

52-Week Data

52-Week High:
53.00
52-Week Low:
12.49

Prediction Charts

Market Cap:
523.25M
Price in USD:
40.27
Volume:
106.84K
Beta:
-1.27

Technical Analysis

SMA50:
38.55
SMA100:
36.57
SMA200:
33.40
52-Wk Change:
168.47%

Stock Predictions

  • Is Neurogene stock public?
    Yes, Neurogene is a publicly traded company.
  • What is the Neurogene stock quote today?
    The Neurogene stock price is 40.27 USD today.
  • How to buy Neurogene stock online?
    You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-28 35.50 35.75 37.42 35.27
Aug-29 35.91 36.40 37.42 35.02
Aug-30 36.90 37.32 38.17 35.91
Sep-3 37.10 32.75 38.00 32.62
Sep-4 32.32 34.50 34.70 32.15
Sep-5 34.84 34.25 35.89 34.07
Sep-6 34.14 35.02 36.63 32.47
Sep-9 34.93 35.13 37.95 34.00
Sep-10 35.00 37.93 37.97 34.80
Sep-11 37.51 39.34 40.52 35.57
Sep-12 39.30 40.36 42.00 38.63
Sep-13 40.98 41.95 43.25 40.66
Sep-16 42.49 42.76 43.92 40.70
Sep-17 43.17 40.27 44.00 38.17

Neurogene Earnings

Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurogene Forecast Revenue Growth

Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.

* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.